Does Dr. ULRIC BIGBY have financial conflicts of interest?

Dr. ULRIC BIGBY (MD) has received a total of $628 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $628 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ULRIC BIGBY?

According to CMS Open Payments data, Dr. ULRIC BIGBY received funding from ZIMMER BIOMET HOLDINGS ($582), FERRING PHARMACEUTICALS ($32), and PROGENACARE GLOBAL ($14).

Does Dr. ULRIC BIGBY receive research grants or speaking fees?

Dr. ULRIC BIGBY has received $628 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. ULRIC BIGBY

MDReal-Time Hydrated

Specialty: Orthopaedic Surgery, Adult Reconstructive Orthopaedic Surgery

Practice Location: ARNOLD, MD 21012

NPI Number: 1306074901

LIFETIME INDUSTRY VALUE

$628

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BIGBY is a verified Orthopaedic Surgery, Adult Reconstructive Orthopaedic Surgery practitioner based in ARNOLD, MD.

Between 2021 and 2025, Dr. BIGBY had an overall industry promotional and research financial footprint of $628 as recorded in the federal CMS Open Payments database.

$628 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BIGBY's primary funding source is ZIMMER BIOMET HOLDINGS, which accounts for $582 (representing 92.7% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ZIMMER BIOMET HOLDINGS

Rank 1

$582

92.7%

FERRING PHARMACEUTICALS

Rank 2

$32

5.1%

PROGENACARE GLOBAL

Rank 3

$14

2.2%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.